Lower Risk Across All Key Outcomes with GLP-1RA Compared with DPP-4 inhibitors, GLP-1RA use was associated with significantly lower risks of MACE (hazard ratio [HR]: 0.66), VTE (HR: 0.49), kidney disease progression (HR: 0.77), and all-cause mortality (HR: 0.26)
Follow dietary recommendations and exercise regularly for optimal results
Abbreviations ER endoplasmic reticulum PDH pyruvate dehydrogenase TCA tricarboxylic acid CPT1 carnitine palmitoyltransferase 1 TMAO trimethylamine N-oxide OCTN2 organic cation transporter novel 2 BBB blood-brain barrier PCD primary carnitine deficiency FAO fatty acid oxidation CPT2 carnitine palmitoyltransferase 2 CAT carnitine acetyltransferase INF- interferon TNF- tumor necrosis factor- IDH1 isocitrate dehydrogenase 1 ROS reactive oxygen species PPAR peroxisome proliferator-activated receptor PPAR peroxisome proliferator-activated receptor GBM glioblastoma ER+ estrogen receptor positive CRC colorectal cancer OCT organic cation transporter IngMeb ingenol mebutate
Particles are unambiguous
Mounjaro may be suitable for adults who: Have a BMI of 30kg/m2 or higher, or Have a BMI of 27kg/m2 or higher with weight-related conditions, such as type 2 diabetes, high blood pressure, high cholesterol or sleep apnoea